incorporating 2-aryl-5-nitro-1H-indole moieties as potential bacterial NorA efflux pump inhibitors, the compound 1-[2-(5-nitro-1H-indol-2-yl)phenyl]methylpyridinium chloride (2) was synthesized and structurally characterized. This pyridinium chloride salt crystallized in the monoclinic space group P2(1)/c with the following unit cell dimensions: a 10.274(3) Å, b 13.101(4) Å, c 13.439(4) Å, b 107.702(7)°, V
在结合 2-芳基-5-硝基-1H-
吲哚部分作为潜在细菌 NorA 外排泵
抑制剂的杂化抗菌剂的研究过程中,化合物 1-[2-(5-硝基-1H-
吲哚-2-基)苯基]
甲基吡啶鎓
氯化物 (2) 已合成并进行结构表征。这种
氯化
吡啶盐在单斜空间群 P2(1)/c 中结晶,具有以下晶胞尺寸:a 10.274(3) Å, b 13.101(4) Å, c 13.439(4) Å, b 107.702(7)° , V 1723.2(9) ų, Z (fu) = 4; R1 = 0.048,wR2 = 0.13。单晶 X 射线结构中令人感兴趣的是
吡啶鎓平面在
吲哚杂环残基上的(分子内)布置 [平面二面角 17.91(4)°]。